| A small number of vaccines against COVID-19 have been authorized since 2020. |
| Pharmacovigilance systems are imperative to ensure the safety of COVID-19 vaccines. |
| Active pharmacovigilance monitoring involving all stakeholders of COVID-19 vaccination is needed to prevent and document possible adverse events related to COVID-19 vaccines. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.